Hemangiopericytoma and antiangiogenic therapy: clinical benefit of antiangiogenic therapy (sorafenib and sunitinib) in relapsed malignant haemangioperyctoma /solitary fibrous tumour

MeSH terms

• Aged
• Angiogenesis Inhibitors / therapeutic use*
• Benzenesulfonates / therapeutic use*
• Fatal Outcome
• Female
• Hemangiopericytoma / blood supply*
• Hemangiopericytoma / diagnostic imaging
• Hemangiopericytoma / drug therapy
• Humans
• Indoles / therapeutic use*
• Middle Aged
• Neovascularization, Pathologic / diagnostic imaging
• Neovascularization, Pathologic / drug therapy*
• Niacinamide / analogs & derivatives
• Phenylurea Compounds
• Pyridines / therapeutic use*
• Pyrroles / therapeutic use*
• Recurrence
• Solitary Fibrous Tumors / blood supply*
• Solitary Fibrous Tumors / diagnostic imaging
• Solitary Fibrous Tumors / drug therapy*
• Sorafenib
• Sunitinib
• Tomography, X-Ray Computed
• Ultrasonography